In vivo assessment of the permeability of the blood-brain barrier and blood-retinal barrier to fluorescent indoline derivatives in zebrafish

BMC Neuroscience

Volumn 13, Issue 1, 2012, Pages

  Watanabe, Kohei ^d   Nishimura, Yuhei ^a,b,c   Nomoto, Tsuyoshi ^d   Umemoto, Noriko ^a   Zhang, Zi ^a   Zhang, Beibei ^a   Kuroyanagi, Junya ^a   Shimada, Yasuhito ^a   Shintou, Taichi ^d   Okano, Mie ^d   Miyazaki, Takeshi ^d   Imamura, Takeshi ^d   Tanaka, Toshio ^a,b,c,e  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c MIE UNIVERSITY   (Japan)

^d CANON INC   (Japan)

^e Canon Inc ^*  (Japan)

Author keywords

Blood brain barrier; Blood retinal barrier; Fluorescent indoline derivatives; Transporters; Zebrafish

Indexed keywords

CARBENE; DIAGNOSTIC AGENT; INDOLE DERIVATIVE; MULTIDRUG RESISTANCE PROTEIN; UNCLASSIFIED DRUG; VERLUKAST; ZMB 034; ZMB 740; ZMB 996; ZMC 213; ZMC 808; ZMJ 018; ZMJ O18;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BLOOD RETINA BARRIER; CONTROLLED STUDY; FERTILIZATION; FLUORESCENCE IMAGING; IMMERSION; IN VIVO STUDY; INFORMATION PROCESSING; LARVA; NONHUMAN; STATISTICAL SIGNIFICANCE; VALIDITY; ZEBRA FISH;

EID: 84864948753     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-13-101     Document Type: Article

References (42)

1. Loscher W, Potschka H. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Prog Neurobiol 2005, 76(1):22-76. 10.1016/j.pneurobio.2005.04.006, 16011870.
2. Hitchcock SA, Pennington LD. Structure-brain exposure relationships. J Med Chem 2006, 49(26):7559-7583. 10.1021/jm060642i, 17181137.
3. Pardridge WM. Blood-brain barrier delivery. Drug Discov Today 2007, 12(1-2):54-61.
4. Hitchcock SA. Blood-brain barrier permeability considerations for CNS-targeted compound library design. Curr Opin Chem Biol 2008, 12(3):318-323. 10.1016/j.cbpa.2008.03.019, 18435937.
5. Neuwelt E, Abbott NJ, Abrey L, Banks WA, Blakley B, Davis T, Engelhardt B, Grammas P, Nedergaard M, Nutt J, et al. Strategies to advance translational research into brain barriers. Lancet Neurol 2008, 7(1):84-96. 10.1016/S1474-4422(07)70326-5, 18093565.
6. Reichel A. Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept. Chem Biodivers 2009, 6(11):2030-2049. 10.1002/cbdv.200900103, 19937839.
7. Eyal S, Hsiao P, Unadkat JD. Drug interactions at the blood-brain barrier: fact or fantasy?. Pharmacol Ther 2009, 123(1):80-104. 10.1016/j.pharmthera.2009.03.017, 2751796, 19393264.
8. Jeffrey P, Summerfield S. Assessment of the blood-brain barrier in CNS drug discovery. Neurobiol Dis 2010, 37(1):33-37. 10.1016/j.nbd.2009.07.033, 19664709.
9. Urquhart BL, Kim RB. Blood-brain barrier transporters and response to CNS-active drugs. Eur J Clin Pharmacol 2009, 65(11):1063-1070. 10.1007/s00228-009-0714-8, 19727692.
10. Mensch J, Oyarzabal J, Mackie C, Augustijns P. In vivo, in vitro and in silico methods for small molecule transfer across the BBB. J Pharm Sci 2009, 98(12):4429-4468. 10.1002/jps.21745, 19408294.
11. Lee JS, Vendrell M, Chang YT. Diversity-oriented optical imaging probe development. Curr Opin Chem Biol 2011, 15(6):760-7. 10.1016/j.cbpa.2011.10.007, 22055497.
12. Jeong JY, Kwon HB, Ahn JC, Kang D, Kwon SH, Park JA, Kim KW. Functional and developmental analysis of the blood-brain barrier in zebrafish. Brain Res Bull 2008, 75(5):619-628. 10.1016/j.brainresbull.2007.10.043, 18355638.
13. Xie J, Farage E, Sugimoto M, Anand-Apte B. A novel transgenic zebrafish model for blood-brain and blood-retinal barrier development. BMC Dev Biol 2010, 10:76. 10.1186/1471-213X-10-76, 2914679, 20653957.
14. Zheng PP, Romme E, van der Spek PJ, Dirven CM, Willemsen R, Kros JM. Glut1/SLC2A1 is crucial for the development of the blood-brain barrier in vivo. Ann Neurol 2010, 68(6):835-844. 10.1002/ana.22318, 21194153.
15. Watanabe K, Nishimura Y, Oka T, Nomoto T, Kon T, Shintou T, Hirano M, Shimada Y, Umemoto N, Kuroyanagi J, et al. In vivo imaging of zebrafish retinal cells using fluorescent coumarin derivatives. BMC Neurosci 2010, 11(1):116. 10.1186/1471-2202-11-116, 2945357, 20843315.
16. Robles E, Smith SJ, Baier H. Characterization of genetically targeted neuron types in the zebrafish optic tectum. Front Neural Circuits 2011, 5:1. 3046383, 21390291.
17. Long Y, Li Q, Cui Z. Molecular analysis and heavy metal detoxification of ABCC1/MRP1 in zebrafish. Mol Biol Rep 2011, 38(3):1703-1711. 10.1007/s11033-010-0283-z, 20842442.
18. Long Y, Li Q, Wang Y, Cui Z. MRP proteins as potential mediators of heavy metal resistance in zebrafish cells. Comp Biochem Physiol C Toxicol Pharmacol 2011, 153(3):310-317. 10.1016/j.cbpc.2010.12.001, 21147257.
19. Gerlai R. Using Zebrafish to unravel the genetics of complex brain disorders. Curr Top Behav Neurosci 2012, 12:3-24.
20. Jesuthasan S. Fear, anxiety, and control in the zebrafish. Dev Neurobiol 2012, 72(3):395-403. 10.1002/dneu.20873, 22328274.
21. Miklosi A, Andrew RJ. The zebrafish as a model for behavioral studies. Zebrafish 2006, 3(2):227-234. 10.1089/zeb.2006.3.227, 18248263.
22. Tropepe V, Sive HL. Can zebrafish be used as a model to study the neurodevelopmental causes of autism?. Genes Brain Behav 2003, 2(5):268-281. 10.1034/j.1601-183X.2003.00038.x, 14606692.
23. Oka T, Nishimura Y, Zang L, Hirano M, Shimada Y, Wang Z, Umemoto N, Kuroyanagi J, Nishimura N, Tanaka T. Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity. BMC Physiol 2010, 10:21. 10.1186/1472-6793-10-21, 2972245, 20961460.
24. Zon LI, Peterson RT. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 2005, 4(1):35-44. 10.1038/nrd1606, 15688071.
25. Sipes NS, Padilla S, Knudsen TB. Zebrafish: as an integrative model for twenty-first century toxicity testing. Birth Defects Res C Embryo Today 2011, 93(3):256-267. 10.1002/bdrc.20214, 21932434.
26. Annilo T, Chen ZQ, Shulenin S, Costantino J, Thomas L, Lou H, Stefanov S, Dean M. Evolution of the vertebrate ABC gene family: analysis of gene birth and death. Genomics 2006, 88(1):1-11. 10.1016/j.ygeno.2006.03.001, 16631343.
27. Dallas S, Zhu X, Baruchel S, Schlichter L, Bendayan R. Functional expression of the multidrug resistance protein 1 in microglia. J Pharmacol Exp Ther 2003, 307(1):282-290. 10.1124/jpet.103.054304, 12893836.
28. Nielsen PA, Andersson O, Hansen SH, Simonsen KB, Andersson G. Models for predicting blood-brain barrier permeation. Drug Discov Today 2011, 16(11-12):472-475.
29. Liu X, Chen C, Smith BJ. Progress in brain penetration evaluation in drug discovery and development. J Pharmacol Exp Ther 2008, 325(2):349-356. 10.1124/jpet.107.130294, 18203948.
30. Sun H, Bungay PM, Elmquist WF. Effect of capillary efflux transport inhibition on the determination of probe recovery during in vivo microdialysis in the brain. J Pharmacol Exp Ther 2001, 297(3):991-1000.
31. On NH, Chen F, Hinton M, Miller DW. Assessment of P-glycoprotein activity in the Blood-brain Barrier (BBB) using Near Infrared Fluorescence (NIRF) imaging techniques. Pharm Res 2011, 28(10):2505-2515. 10.1007/s11095-011-0478-6, 21598079.
32. Horiuchi T, Miura H, Sumioka K, Uchida S. High efficiency of dye-sensitized solar cells based on metal-free indoline dyes. J Am Chem Soc 2004, 126(39):12218-12219. 10.1021/ja0488277, 15453726.
33. Peterson RT, Fishman MC. Discovery and use of small molecules for probing biological processes in zebrafish. Methods Cell Biol 2004, 76:569-591.
34. Padilla S, Corum D, Padnos B, Hunter DL, Beam A, Houck KA, Sipes N, Kleinstreuer N, Knudsen T, Dix DJ, et al. Zebrafish developmental screening of the ToxCast Phase I chemical library. Reprod Toxicol 2012, 33(2):174-187. 10.1016/j.reprotox.2011.10.018, 22182468.
35. White RM, Sessa A, Burke C, Bowman T, LeBlanc J, Ceol C, Bourque C, Dovey M, Goessling W, Burns CE, et al. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2008, 2(2):183-189. 10.1016/j.stem.2007.11.002, 2292119, 18371439.
36. Kelsh RN, Brand M, Jiang YJ, Heisenberg CP, Lin S, Haffter P, Odenthal J, Mullins MC, van Eeden FJ, Furutani-Seiki M, et al. Zebrafish pigmentation mutations and the processes of neural crest development. Development 1996, 123:369-389.
37. O'Malley DM, Sankrithi NS, Borla MA, Parker S, Banden S, Gahtan E, Detrich HW. Optical physiology and locomotor behaviors of wild-type and nacre zebrafish. Methods Cell Biol 2004, 76:261-284.
38. Parichy DM, Mellgren EM, Rawls JF, Lopes SS, Kelsh RN, Johnson SL. Mutational analysis of endothelin receptor b1 (rose) during neural crest and pigment pattern development in the zebrafish Danio rerio. Dev Biol 2000, 227(2):294-306. 10.1006/dbio.2000.9899, 11071756.
39. Westerfield M. The Zebrafish Book. A guide for the laboratory use of zebrafish (Danio rerio) 2007, Eugene: Univ. of Oregon Press, 5.
40. Nasevicius A, Larson J, Ekker SC. Distinct requirements for zebrafish angiogenesis revealed by a VEGF-A morphant. Yeast 2000, 17(4):294-301. 10.1002/1097-0061(200012)17:4<294::AID-YEA54>3.0.CO;2-5, 2448381, 11119306.
41. Thomas LT, Welsh L, Galvez F, Svoboda KR. Acute nicotine exposure and modulation of a spinal motor circuit in embryonic zebrafish. Toxicol Appl Pharmacol 2009, 239(1):1-12. 10.1016/j.taap.2008.08.023, 19121331.
42. Huang H, Huang C, Wang L, Ye X, Bai C, Simonich MT, Tanguay RL, Dong Q. Toxicity, uptake kinetics and behavior assessment in zebrafish embryos following exposure to perfluorooctanesulphonicacid (PFOS). Aquat Toxicol 2010, 98(2):139-147. 10.1016/j.aquatox.2010.02.003, 20171748.